Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares stood at 0.34 million during the last session, with the company’s beta value hitting 0.65. At the close of
In last trading session, Relmada Therapeutics Inc (NASDAQ:RLMD) saw 0.74 million shares changing hands with its beta currently measuring 0.61. Company’s recent per share price
Relmada Therapeutics Inc (NASDAQ:RLMD) has a beta value of 0.61 and has seen 1.27 million shares traded in the last trading session. The RLMD stock
During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 1.27 million, with the beta value of the company hitting 0.62. At the end
In the last trading session, 2.86 million shares of the Relmada Therapeutics Inc (NASDAQ:RLMD) were traded, and its beta was 0.61. Most recently the company’s
Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares stood at 25.82 million during the last session, with the company’s beta value hitting 0.60. At the close of
Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares stood at 1.1 million during the last session, with the company’s beta value hitting 0.61. At the close of
In last trading session, Relmada Therapeutics Inc (NASDAQ:RLMD) saw 0.34 million shares changing hands with its beta currently measuring 0.49. Company’s recent per share price
During the last session, Relmada Therapeutics Inc (NASDAQ:RLMD)’s traded shares were 0.31 million, with the beta value of the company hitting 0.48. At the end
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
